Carisma Therapeutics' CT-0525 IND application receives US FDA approval

Orexo's OX124 New Drug Application accepted for review by US Food and Drug Administration

GE HealthCare expands Critical Care Suite with FDA-cleared Pneumothorax detection algorithm

NanoVibronix initiates clinical study for UroShield at University of Michigan

Acrivon Therapeutics secures FDA Breakthrough Device designation for ACR-368 OncoSignature assay

Orexo's opioid overdose rescue medication, OX124, gains FDA acceptance for review

TC BioPharm's TCB008 IND application for Phase 1B study in relapse/refractory Acute Myeloid Leukaemia receives US FDA approval

SpringWorks Therapeutics' Ogsiveo tablets receive US FDA approval

RedHill Biopharma granted five years' market exclusivity for Talicia by US FDA

Arcturus Therapeutics granted FDA Orphan Drug Designation for ARCT-032 to treat cystic fibrosis

Genelux secures FDA Fast Track designation for Olvi-Vec in ovarian cancer

Acadia Pharmaceuticals announces start of Phase 2 trial for ACP-204 to treat Alzheimer's disease psychosis

EMA accepts Valneva's chikungunya vaccine application for accelerated assessment

Dupixent shows significant COPD exacerbation reduction in Phase 3 trial, accelerating FDA submission

Everest Medicines Nefecon receives Chinese regulatory approval